COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Letter

COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD

Free

Online download statistics by month:

Online download statistics by month: April 2020 to February 2023

	Abstract	Full	Pdf
Apr 2020	4825	4572	2203
May 2020	2315	1959	873
Jun 2020	716	595	293
Jul 2020	476	363	174
Aug 2020	304	251	81
Sep 2020	297	226	111
Oct 2020	249	223	80
Nov 2020	171	149	82
Dec 2020	183	154	56
Jan 2021	229	204	75
Feb 2021	166	151	45
Mar 2021	339	139	63
Apr 2021	196	163	53
May 2021	191	166	51
Jun 2021	107	99	40
Jul 2021	119	106	21
Aug 2021	96	87	37
Sep 2021	115	106	41
Oct 2021	115	100	40
Nov 2021	90	81	25
Dec 2021	118	88	18
Jan 2022	109	99	30
Feb 2022	85	71	22
Mar 2022	119	102	24
Apr 2022	82	71	27
May 2022	77	51	26
Jun 2022	77	63	22
Jul 2022	50	42	13
Aug 2022	74	66	19
Sep 2022	83	77	15
Oct 2022	71	58	28
Nov 2022	62	54	21
Dec 2022	49	44	23
Jan 2023	54	50	11
Feb 2023	77	77	11
Total	12486	10907	4754